简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

J.W. Mays(纳斯达克股票代码:MAYS)股价突破五十天移动平均线45.27美元

2023-02-18 17:02

J.W. Mays, Inc. (NASDAQ:MAYS – Get Rating)'s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $45.27 and traded as high as $45.30. J.W. Mays shares last traded at $45.30, with a volume of 721 shares traded.

J.W. Mays Trading Up 10.5 %

The company has a quick ratio of 3.86, a current ratio of 3.86 and a debt-to-equity ratio of 0.13. The firm's 50-day moving average price is $45.27 and its 200 day moving average price is $46.37. The company has a market capitalization of $91.51 million, a P/E ratio of -348.46 and a beta of 0.03.

Get J.W. Mays alerts:

J.W. Mays (NASDAQ:MAYS – Get Rating) last issued its quarterly earnings data on Thursday, December 8th. The financial services provider reported $0.12 earnings per share (EPS) for the quarter. J.W. Mays had a negative net margin of 1.19% and a negative return on equity of 0.14%. The business had revenue of $5.77 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in J.W. Mays stock. Jane Street Group LLC bought a new stake in J.W. Mays, Inc. (NASDAQ:MAYS – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,114 shares of the financial services provider's stock, valued at approximately $354,000. Jane Street Group LLC owned about 0.35% of J.W. Mays as of its most recent SEC filing. 2.95% of the stock is owned by institutional investors.

About J.W. Mays

(Get Rating)

J.W. Mays, Inc engages in the operation of commercial real estate properties. The company was founded in 1924 and is headquartered in Brooklyn, NY.

Featured Stories

  • Get a free copy of the StockNews.com research report on J.W. Mays (MAYS)
  • Deere Stock Raises Outlook and is Ready to Power Higher
  • DraftKings Crowning Achievement: Leverage
  • Tesla Stock Comeback Is Picking Up Steam
  • How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
  • Is it Time to Fade the Rally in Generac Stock?

Receive News & Ratings for J.W. Mays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J.W. Mays and related companies with MarketBeat.com's FREE daily email newsletter.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。